Fundraising FoxFount Bio
Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Fount Bio
Sign up to see every warm intro you have to Fount Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fount Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fount Bio is a life science company developing a pipeline of products for medical and beauty applications, combining bioorthogonal chemistry with glycopolymer science. It targets the aesthetics, consumer beauty, and medicine markets.
Founders & leadership
DL
Douglas LevinsonNamed on SEC filing
AA
Anthony AiudiNamed on SEC filing
SM
Samir MitragotriNamed on SEC filing
JB
Justin BurnsNamed on SEC filing
Investors · 1
Also in the syndicate · 1
Morningside Ventureslead
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2021
▶$8.2MraisedJul 2021 · 14 investors · OtherRule 506(b)
▶$8.2MraisedJul 2021 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Douglas LevinsonExecutive Officer, Director
- Anthony AiudiDirector
- Samir MitragotriDirector
- Justin BurnsDirector
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Intuitive BiosciencesIntuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
Fauna BioFauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans. The biotech company focuses on discovering novel therapeutics for human diseases based on evolutionary and genomic insights.
Octant BioOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Fortress BiotechFortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
Companies working in the same space as Fount Bio.
In the news
Frequently asked questions
- What does Fount Bio do?
- Fount Bio is a life science company developing a pipeline of products for medical and beauty applications, combining bioorthogonal chemistry with glycopolymer science. It targets the aesthetics, consumer beauty, and medicine markets.
- How much funding has Fount Bio raised?
- Fount Bio has disclosed $8.2M raised across 1 round.
- Where is Fount Bio headquartered?
- Fount Bio is headquartered in Cambridge, US.